{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:55:43Z","timestamp":1782392143878,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Determine if previously described sepsis survivor subtypes can be applied outside of their derivation cohort using a parsimonious algorithm. Test the association between subtype and the primary outcome of 3-month mortality, and secondary outcomes of readmission, physical function, and health-related quality of life through 1 year of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Participants enrolled in the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial, a multisite trial in the United States that enrolled patients with sepsis-induced hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>All participants who were alive on day 28 after enrollment and had nonmissing data for outcome and subtype-defining variables (Charlson Comorbidity Index, length of stay, discharge destination). Participants were retrospectively assigned at time of discharge to one of five previously derived survivor subtypes: low risk, healthy with severe disease, multimorbidity, low functional status, and unhealthy baseline with severe disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Of 1563 participants, 1368 were eligible and assigned a subtype. Three-month mortality was 13.1% and varied significantly between subtypes (5.1\u201345.5%;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). In age-adjusted logistic regression, odds ratios for 3-month mortality were 11.1 in the low functional status and 9.7 in the unhealthy baseline with severe illness subtypes, compared with the low-risk subtype (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Participant subtype was a significant predictor of 6- and 12-month EuroQol 5D five level score and limitations in activities of daily living, but not readmission.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Sepsis survivor subtypes that are readily identifiable at hospital discharge are significantly associated with mortality at 3 months, and patient-important outcomes through 12 months. Using subtypes to predict a patient\u2019s risk of adverse outcomes could aid the discharge planning and recovery process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006933","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:00:09Z","timestamp":1763046009000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association of Sepsis Survivor Subtypes With Long-Term Mortality and Disability After Discharge: A Retrospective Cohort Study"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-6398","authenticated-orcid":false,"given":"Robert J.","family":"Flick","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee A.","family":"Kamphuis","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Valley","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI"},{"name":"Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Armstrong-Hough","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, New York University School of Global Public Health, New York, NY"},{"name":"Department of Social and Behavioral Sciences, New York University School of Global Public Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Iwashyna","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD"},{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"R1-20260106","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis.","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"R2-20260106","doi-asserted-by":"crossref","first-page":"i2375","DOI":"10.1136\/bmj.i2375","article-title":"Late mortality after sepsis: Propensity matched cohort study.","volume":"353","author":"Prescott","year":"2016","journal-title":"BMJ"},{"key":"R3-20260106","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/CCM.0b013e3181d8cc1d","article-title":"Long-term mortality and quality of life in sepsis: A systematic review.","volume":"38","author":"Winters","year":"2010","journal-title":"Crit Care Med"},{"key":"R4-20260106","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/CCM.0000000000005300","article-title":"Effect of a multicomponent sepsis transition and recovery program on mortality and readmissions after sepsis: The improving morbidity during post-acute care transitions for sepsis randomized clinical trial.","volume":"50","author":"Taylor","year":"2022","journal-title":"Crit Care Med"},{"key":"R5-20260106","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1513\/AnnalsATS.202109-1088OC","article-title":"Clinical subtypes of sepsis survivors predict readmission and mortality after hospital discharge.","volume":"19","author":"Taylor","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"R6-20260106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/CCM.0b013e318232da75","article-title":"Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders\u2019 conference.","volume":"40","author":"Needham","year":"2012","journal-title":"Crit Care Med"},{"key":"R7-20260106","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension.","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"R8-20260106","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"R9-20260106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1519\/JPT.0b013e318268da23","article-title":"The hierarchy of the activities of daily living in the Katz index in residents of skilled nursing facilities.","volume":"36","author":"Gerrard","year":"2013","journal-title":"J Geriatr Phys Ther"},{"key":"R10-20260106","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.apmr.2013.05.014","article-title":"Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank.","volume":"94","author":"Hays","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"R11-20260106","doi-asserted-by":"crossref","first-page":"e214732","DOI":"10.1001\/jamanetworkopen.2021.4732","article-title":"Comparison of clinical characteristics between clinical trial participants and nonparticipants using electronic health record data.","volume":"4","author":"Rogers","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R12-20260106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"R13-20260106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: A secondary analysis of randomised controlled trials.","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R14-20260106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis.","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R15-20260106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: Consensus report and recommendations for developing precision medicine in the ICU.","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20260106","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R17-20260106","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1097\/CCM.0000000000006621","article-title":"Phenotypes of functional decline or recovery in sepsis ICU survivors: Insights from a 1-year follow-up multicenter cohort analysis.","volume":"53","author":"Liu","year":"2025","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:02:07Z","timestamp":1767711727000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006933","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}